Top Page
People's Insurance Co (Group) of China
(1339)
People's Insurance Co (Group) of China (1339) vs. iShares MSCI Hong Kong ETF (EWH)
People's Insurance Co (Group) of China Business Overview & Revenue Model
People's Insurance Co (Group) of China Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 576.06B | 598.79B | 530.21B | 475.09B | 592.01B | 579.07B |
| Gross Profit | 576.06B | 653.20B | 577.73B | 469.88B | 539.73B | 514.55B |
| EBITDA | 0.00 | 77.48B | 42.07B | 52.85B | 45.90B | 41.75B |
| Net Income | 46.71B | 42.15B | 22.32B | 25.37B | 21.48B | 20.04B |
Balance Sheet | ||||||
| Total Assets | 1.88T | 1.77T | 1.56T | 1.51T | 1.38T | 1.26T |
| Cash, Cash Equivalents and Short-Term Investments | 737.01B | 664.26B | 21.87B | 21.36B | 21.79B | 23.13B |
| Total Debt | 41.51B | 52.60B | 40.26B | 46.20B | 47.43B | 60.34B |
| Total Liabilities | 1.49T | 1.40T | 1.23T | 1.21T | 1.08T | 982.51B |
| Stockholders Equity | 285.11B | 268.73B | 242.35B | 221.77B | 219.26B | 202.48B |
Cash Flow | ||||||
| Free Cash Flow | 88.51B | 83.59B | 66.98B | 65.08B | 110.35B | 59.83B |
| Operating Cash Flow | 92.79B | 87.99B | 70.55B | 71.65B | 72.73B | 31.87B |
| Investing Cash Flow | -98.88B | -77.60B | -70.93B | -73.28B | -81.56B | -51.37B |
| Financing Cash Flow | 12.05B | 4.86B | -11.48B | 8.56B | -35.86B | 21.11B |
People's Insurance Co (Group) of China Technical Analysis
People's Insurance Co (Group) of China Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | HK$250.58B | 5.92 | 34.37% | 5.24% | 49.90% | 203.77% | |
78 Outperform | $453.48B | 6.57 | 17.99% | 3.05% | 9.40% | 79.93% | |
76 Outperform | $368.56B | 8.96 | 14.60% | 3.77% | 6.42% | 66.35% | |
76 Outperform | HK$462.47B | 6.55 | 18.41% | 3.28% | 15.08% | 23.13% | |
71 Outperform | $75.47B | 9.24 | 10.74% | 1.81% | 23.64% | 36.32% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$162.40B | 12.16 | 9.41% | 3.83% | 51.04% | 24.56% |
People's Insurance Co (Group) of China Corporate Events
The People’s Insurance Company (Group) of China Limited has confirmed that the appointment of Mr. Jia Ruo as an independent non-executive director has become effective following regulatory approval from the National Financial Regulatory Administration and prior shareholder approval. Mr. Jia also assumes the roles of chairman of the Related Party Transactions Control Committee and member of both the Risk Management & Consumers’ Rights and Interests Protection Committee and the Audit Committee, with his term running until the end of the current board session and remuneration set in line with the company’s director pay structure. Concurrently, long-serving independent non-executive director Mr. Shiu Sin Por has retired from the board and its key committees; he has indicated no disagreement with the board and no matters requiring disclosure, suggesting a smooth transition in the company’s independent oversight and governance framework.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
People’s Insurance Co (Group) of China has announced the current composition of its board of directors, which includes three executive directors, four non-executive directors and four independent non-executive directors, led by Chairperson Ding Xiangqun and Vice Chairman Zhao Peng. The company has also detailed the membership and leadership of its five key board committees covering strategy and investment/sustainable development, risk management and consumer rights protection, audit, nomination and remuneration, and related party transactions control, underscoring its governance structure and oversight framework for strategic planning, risk control, and regulatory compliance in the coming period.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited has obtained approval from China’s National Financial Regulatory Administration for amendments to its Articles of Association, adopted at its 2024 annual general meeting, and has published the revised Articles on the Hong Kong stock exchange website and the company’s own site. Under the new Articles, the company will abolish its Board of Supervisors and transfer its supervisory functions and powers to the audit committee of the board, prompting the simultaneous departure of supervisors Starry Lee Wai King, Wang Yadong and He Zuwang, who stated they had no disagreements with the company; the move marks a significant governance restructuring that consolidates oversight within the board framework and may streamline supervisory processes for shareholders and other stakeholders.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited has appointed Ms. Gao Tian as its new agent to accept service of process and notices in Hong Kong, replacing Mr. Au Lai Chee with effect from 24 December 2025, in accordance with Hong Kong listing rules and the Companies Ordinance. The change is an administrative adjustment to the company’s compliance and legal representation structure in Hong Kong, ensuring continued adherence to regulatory requirements without indicating any shift in broader strategy or operations for shareholders and other stakeholders.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited announced that its Vice President, Mr. Yu Ze, is under investigation by the Central Commission for Discipline Inspection and the National Supervisory Commission for suspected serious violations of discipline and law. Despite the investigation, the company has stated that its management and operations remain unaffected.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited held its 2025 Investor Open Day, emphasizing the theme of ‘Practices and Outlook for the High-Quality Development of Non-Auto Insurance.’ This event underscores the company’s strategic focus on enhancing its non-auto insurance offerings, which may impact its market positioning and stakeholder interests.
The most recent analyst rating on (HK:1339) stock is a Buy with a HK$8.50 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited announced the successful passing of resolutions at its 2025 second extraordinary general meeting, including the approval of the 2025 interim profit distribution. The interim dividend, amounting to RMB3.317 billion, will be distributed to shareholders in December 2025, reflecting the company’s strong financial performance and commitment to shareholder returns.
The most recent analyst rating on (HK:1339) stock is a Buy with a HK$8.50 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited announced an update to its interim cash dividend for the six months ended June 30, 2025. The dividend is set at RMB 0.075 per share, with a corresponding payment in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.09603214. The ex-dividend date is November 4, 2025, and the payment will be made on December 12, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may impact its financial positioning and investor relations positively.
The most recent analyst rating on (HK:1339) stock is a Buy with a HK$8.50 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited reported significant financial growth in its third quarterly report of 2025, with a notable increase in both total operating income and net profit attributable to owners. The company’s total assets and equity have also seen substantial growth, indicating a strong financial position and positive market performance.
The most recent analyst rating on (HK:1339) stock is a Buy with a HK$8.50 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited announced its plan to hold the 2025 Third Quarter Results Announcement through a text interaction session on October 31, 2025. This event will allow investors to engage with the company by submitting questions in advance, which will be addressed during the session, potentially impacting investor relations and market perceptions.
The most recent analyst rating on (HK:1339) stock is a Buy with a HK$8.50 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited has announced a board meeting scheduled for October 30, 2025, to review and approve the unaudited third-quarter results for the period ending September 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.10 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited has announced the scheduling of its 2025 second extraordinary general meeting (EGM) to be held on October 30, 2025. The meeting will address resolutions concerning the 2025 interim profit distribution and amendments to the authorization plan for the Board of Directors. This announcement is significant as it outlines key corporate governance actions that could impact shareholder value and company operations.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.20 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited announced an update to its interim dividend for the six months ended 30 June 2025, declaring a dividend of RMB 0.075 per share. The update includes details on the date of shareholders’ approval, Hong Kong share register information, and withholding tax arrangements. This announcement is significant for stakeholders as it provides clarity on the financial returns and tax implications for both resident and non-resident shareholders, potentially impacting investor decisions and market perception.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.20 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Co (Group) of China has announced the composition of its board of directors and the establishment of five special committees under the board. This organizational structure aims to enhance the company’s strategic direction, risk management, and governance, potentially strengthening its position in the insurance industry and improving stakeholder confidence.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.20 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.
The People’s Insurance Company (Group) of China Limited has announced the appointment of Mr. Xu Xiang as a non-executive director, effective from September 29, 2025, following approval from the National Financial Regulatory Administration. This strategic appointment, which also includes Mr. Xu’s roles in the Risk Management & Consumers’ Rights and Interests Protection Committee and the Nomination and Remuneration Committee, is expected to enhance the company’s governance and oversight capabilities, potentially strengthening its market position and stakeholder confidence.
The most recent analyst rating on (HK:1339) stock is a Hold with a HK$7.20 price target. To see the full list of analyst forecasts on People’s Insurance Co (Group) of China stock, see the HK:1339 Stock Forecast page.